These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36968111)

  • 1. Replication in the presence of dengue convalescent serum impacts Zika virus neutralization sensitivity and fitness.
    Marano JM; Weger-Lucarelli J
    Front Cell Infect Microbiol; 2023; 13():1130749. PubMed ID: 36968111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Zika virus mutation enhances transmission potential and confers escape from protective dengue virus immunity.
    Regla-Nava JA; Wang YT; Fontes-Garfias CR; Liu Y; Syed T; Susantono M; Gonzalez A; Viramontes KM; Verma SK; Kim K; Landeras-Bueno S; Huang CT; Prigozhin DM; Gleeson JG; Terskikh AV; Shi PY; Shresta S
    Cell Rep; 2022 Apr; 39(2):110655. PubMed ID: 35417697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
    Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus.
    Priyamvada L; Quicke KM; Hudson WH; Onlamoon N; Sewatanon J; Edupuganti S; Pattanapanyasat K; Chokephaibulkit K; Mulligan MJ; Wilson PC; Ahmed R; Suthar MS; Wrammert J
    Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7852-7. PubMed ID: 27354515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques.
    Singh T; Miller IG; Venkatayogi S; Webster H; Heimsath HJ; Eudailey JA; Dudley DM; Kumar A; Mangan RJ; Thein A; Aliota MT; Newman CM; Mohns MS; Breitbach ME; Berry M; Friedrich TC; Wiehe K; O'Connor DH; Permar SR
    mBio; 2024 Mar; 15(3):e0316023. PubMed ID: 38349142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions.
    Chen GH; Dai YC; Hsieh SC; Tsai JJ; Sy AK; Jiz M; Pedroso C; Brites C; Netto EM; Kanki PJ; Saunders DRD; Vanlandingham DL; Higgs S; Huang YS; Wang WK
    Emerg Microbes Infect; 2024 Dec; 13(1):2301666. PubMed ID: 38163752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-infection of dengue and Zika viruses mutually enhances viral replication in the mosquito Aedes aegypti.
    Lin DC; Weng SC; Tsao PN; Chu JJH; Shiao SH
    Parasit Vectors; 2023 May; 16(1):160. PubMed ID: 37165438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection, dissemination, and transmission efficiencies of Zika virus in Aedes aegypti after serial passage in mosquito or mammalian cell lines or alternating passage in both cell types.
    Talavera-Aguilar LG; Murrieta RA; Kiem S; Cetina-Trejo RC; Baak-Baak CM; Ebel GD; Blitvich BJ; Machain-Williams C
    Parasit Vectors; 2021 May; 14(1):261. PubMed ID: 34006306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies.
    Contreras M; Stuart JB; Levoir LM; Belmont L; Goo L
    mBio; 2024 Feb; 15(2):e0304823. PubMed ID: 38193697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Degrees of 5'-to-3' DAR Interactions Modulate Zika Virus Genome Cyclization and Host-Specific Replication.
    Li XD; Deng CL; Yuan ZM; Ye HQ; Zhang B
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
    Elong Ngono A; Shresta S
    Front Immunol; 2019; 10():1316. PubMed ID: 31244855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term.
    Katzelnick LC; Zambrana JV; Elizondo D; Collado D; Garcia N; Arguello S; Mercado JC; Miranda T; Ampie O; Mercado BL; Narvaez C; Gresh L; Binder RA; Ojeda S; Sanchez N; Plazaola M; Latta K; Schiller A; Coloma J; Carrillo FB; Narvaez F; Halloran ME; Gordon A; Kuan G; Balmaseda A; Harris E
    Sci Transl Med; 2021 Oct; 13(614):eabg9478. PubMed ID: 34613812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody cross-reactivity and evidence of susceptibility to emerging Flaviviruses in the dengue-endemic Brazilian Amazon.
    Salgado BB; Maués FCJ; Jordão M; Pereira RL; Toledo-Teixeira DA; Parise PL; Granja F; Souza HFS; Yamamoto MM; Chiang JO; Martins LC; Boscardin SB; Lalwani JDB; Vasconcelos PFC; Proença-Modena JL; Lalwani P
    Int J Infect Dis; 2023 Apr; 129():142-151. PubMed ID: 36736575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zika Virus Subgenomic Flavivirus RNA Generation Requires Cooperativity between Duplicated RNA Structures That Are Essential for Productive Infection in Human Cells.
    Pallarés HM; Costa Navarro GS; Villordo SM; Merwaiss F; de Borba L; Gonzalez Lopez Ledesma MM; Ojeda DS; Henrion-Lacritick A; Morales MA; Fabri C; Saleh MC; Gamarnik AV
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32581095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Circulation of All Four Dengue Viruses and Zika Virus in Guerrero, Mexico, 2019.
    Nunez-Avellaneda D; Tangudu C; Barrios-Palacios J; Machain-Williams C; Alarcón-Romero LDC; Zubillaga-Guerrero MI; Nunez-Avellaneda S; McKeen LA; Canche-Aguilar I; Loaeza-Díaz L; Blitvich BJ
    Vector Borne Zoonotic Dis; 2021 Jun; 21(6):458-465. PubMed ID: 33944623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombination of B- and T-cell epitope-rich loci from Aedes- and Culex-borne flaviviruses shapes Zika virus epidemiology.
    Gaunt MW; Gubler DJ; Pettersson JH; Kuno G; Wilder-Smith A; de Lamballerie X; Gould EA; Falconar AK
    Antiviral Res; 2020 Feb; 174():104676. PubMed ID: 31837392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection.
    Bonheur AN; Thomas S; Soshnick SH; McGibbon E; Dupuis AP; Hull R; Slavinski S; Del Rosso PE; Weiss D; Hunt DT; McCabe ME; Dean AB; Folkerth R; Laib AM; Wong SJ
    BMC Infect Dis; 2021 Aug; 21(1):749. PubMed ID: 34348665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.